NCT03775213View on ClinicalTrials.gov

Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS)

NACompletedINTERVENTIONAL
Enrollment

322

Participants

Timeline

Start Date

October 12, 2021

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions
Ductal Carcinoma in Situ
Interventions
BEHAVIORAL

Decision Support Tool with Active Monitoring

The decision support tool communicates trade-offs for different management strategies for DCIS, including active monitoring and surgery options.

BEHAVIORAL

Decision Support Tool without Active Monitoring

The decision support tool communicates trade-offs for different management strategies for DCIS, including surgery options only.

Trial Locations (1)

27710

Duke Mammography Clinic, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER